The case of the missing mouse-developing cystic fibrosis drugs without using animals
Creating and developing new drugs can take decades, costs millions of dollars, requires untold human effort and usually, takes thousands of animal lives. Despite regulators professing confidence in non-animal approaches and guidance documents that permit submission of non-animal data, toxicity testi...
Saved in:
Main Authors: | Lindsay J. Marshall (Author), Kathleen M. Conlee (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Animal Models in the Pathophysiology of Cystic Fibrosis
by: Anna Semaniakou, et al.
Published: (2019) -
Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening-Towards a Consistent Definition and Data Acquisition
by: Anne Munck, et al.
Published: (2023) -
Burkholderia cepacia infection in children without cystic fibrosis: a clinical analysis of 50 cases
by: Huixuan Shi, et al.
Published: (2023) -
Little Miss Mouse
by: Blanchard, Amy Ella, 1856-1926 -
New Developments in Cystic Fibrosis Airway Inflammation
by: Nades Palaniyar, et al.
Published: (2015)